CA2155330A1 - Human neuronal nicotinic acetylcholine receptor compositions and methods employing same - Google Patents
Human neuronal nicotinic acetylcholine receptor compositions and methods employing sameInfo
- Publication number
- CA2155330A1 CA2155330A1 CA002155330A CA2155330A CA2155330A1 CA 2155330 A1 CA2155330 A1 CA 2155330A1 CA 002155330 A CA002155330 A CA 002155330A CA 2155330 A CA2155330 A CA 2155330A CA 2155330 A1 CA2155330 A1 CA 2155330A1
- Authority
- CA
- Canada
- Prior art keywords
- alpha
- subunits
- beta
- acetylcholine receptor
- nicotinic acetylcholine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
Abstract
Nucleic acids encoding human neuronal nicotinic acetylcholine receptor alpha and beta subunits, mammalian and amphibian cells containing said nucleic acids, methods for producing alpha and beta subunits and recombinant (i.e., isolated or substantially pure) alpha subunits (specifically .alpha.4 and .alpha.7) and beta subunits (specifically (.beta.4) are provided. In addition, combinations of subunits (i.e., .alpha.1, .alpha.2, .alpha.3, .alpha.4, and/or .alpha.7 subunits in combination with .beta.4 subunits; or (.beta.2, .beta.3 and/or .beta.4 subunits in combination with .alpha.4 and/or .alpha.7 subunits) are provided.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2803193A | 1993-03-08 | 1993-03-08 | |
US08/028,031 | 1993-03-08 | ||
PCT/US1994/002447 WO1994020617A2 (en) | 1993-03-08 | 1994-03-08 | Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2155330A1 true CA2155330A1 (en) | 1994-09-15 |
CA2155330C CA2155330C (en) | 2002-01-29 |
Family
ID=21841175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002155330A Expired - Fee Related CA2155330C (en) | 1993-03-08 | 1994-03-08 | Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
Country Status (10)
Country | Link |
---|---|
US (5) | US6022704A (en) |
EP (2) | EP0688361B1 (en) |
JP (2) | JP3628691B2 (en) |
AT (1) | ATE279516T1 (en) |
AU (1) | AU694424B2 (en) |
CA (1) | CA2155330C (en) |
DE (1) | DE69434067T2 (en) |
ES (1) | ES2229216T3 (en) |
GB (1) | GB2286397B (en) |
WO (1) | WO1994020617A2 (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6936457B1 (en) * | 1990-04-03 | 2005-08-30 | Merck & Co., Inc. | DNA ENCODING HUMAN α AND β SUBUNITS OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR, CELLS TRANSFORMED THEREWITH, AND RECOMBINANT CELL LINE EXPRESSING A HUMAN α AND β SUBUNIT OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR |
WO1994020617A2 (en) | 1993-03-08 | 1994-09-15 | The Salk Institute Biotechnology/Industrial Associates, Incorporated | Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
US6485967B1 (en) * | 1995-06-07 | 2002-11-26 | Merck & Co., Inc. | Human neuronal nicotinic acetylcholine receptor α6 and β3 nucleic acid |
CA2279669A1 (en) * | 1995-12-15 | 1997-06-16 | Enzo Therapeutics, Inc. | Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acid processing components for therapeutic and diagnostic uses |
US6323000B2 (en) | 1996-12-20 | 2001-11-27 | Clark A. Briggs | Variant human α7 acetylcholine receptor subunit, and methods of production and uses thereof |
EP0988395A2 (en) * | 1997-06-13 | 2000-03-29 | Allelix Biopharmaceuticals Inc. | Assay methods and compositions useful for measuring receptor ligand binding |
US6875606B1 (en) * | 1997-10-23 | 2005-04-05 | The United States Of America As Represented By The Department Of Veterans Affairs | Human α-7 nicotinic receptor promoter |
US6632823B1 (en) | 1997-12-22 | 2003-10-14 | Merck & Co., Inc. | Substituted pyridine compounds useful as modulators of acetylcholine receptors |
EP0953637A3 (en) * | 1998-03-24 | 2001-04-25 | Smithkline Beecham Plc | Acetylcholine receptor |
US6252132B1 (en) | 1998-11-02 | 2001-06-26 | Institut Pasteur | Mutant mouse containing a knockout mutation in DNA encoding an endogenous alpha 4 subunit of nicotinic acetylcholine receptor |
US6693172B1 (en) | 1999-05-27 | 2004-02-17 | Pharmacia And Upjohn Company | Double mutant alpha-7 nicotinic acetylcholine receptor |
WO2000073431A2 (en) * | 1999-05-27 | 2000-12-07 | Pharmacia & Upjohn Company | Methods and compositions for measuring ion channel conductance |
GB9913248D0 (en) * | 1999-06-09 | 1999-08-04 | Babraham Inst | Recombinant nematode nicotinic receptor and uses |
US20030096411A1 (en) * | 1999-12-07 | 2003-05-22 | George Michalopoulos | Novel long-term three-dimensional tissue culture system |
US6737270B1 (en) | 1999-12-07 | 2004-05-18 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Long-term three dimensional tissue culture system |
DE19959582A1 (en) * | 1999-12-10 | 2001-06-13 | Bayer Ag | Nucleic acids encoding new acetylcholine receptor beta subunits of insects |
GB2364385B (en) * | 2000-03-29 | 2002-08-14 | Synaptica Ltd | Alpha 7 nicotinic receptor screening assays |
JP2004506735A (en) | 2000-08-18 | 2004-03-04 | ファルマシア・アンド・アップジョン・カンパニー | Quinuclidine-substituted aryl compounds for disease treatment |
US6486172B2 (en) | 2000-08-18 | 2002-11-26 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
US6492385B2 (en) | 2000-08-18 | 2002-12-10 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease |
US6599916B2 (en) | 2000-08-21 | 2003-07-29 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease |
AU2001282875A1 (en) | 2000-08-21 | 2002-03-04 | Pharmacia And Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease |
EP1334130A2 (en) * | 2000-10-31 | 2003-08-13 | Bayer Ag | Regulation of human serotonin receptor precursor |
PE20021019A1 (en) | 2001-04-19 | 2002-11-13 | Upjohn Co | SUBSTITUTED AZABYCLE GROUPS |
IL160651A0 (en) * | 2001-08-31 | 2004-07-25 | Agensys Inc | Nucleic acid and correspondidng protein entitled 205pib5 and pharmaceutical compositions containing the same |
US20030194720A1 (en) * | 2001-09-12 | 2003-10-16 | Roberds Steven L. | Human ion channels |
US7229779B2 (en) | 2001-09-18 | 2007-06-12 | Abbott Laboratories | Variant human α7 acetylcholine receptor subunit, and methods of production and use thereof |
US20060126682A1 (en) * | 2001-10-08 | 2006-06-15 | Geola Technologies Ltd. | Pulsed multiple colour laser system |
WO2003095976A2 (en) * | 2002-05-09 | 2003-11-20 | Memory Pharmaceuticals Corporation | Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
AU2003253686A1 (en) * | 2002-08-01 | 2004-02-23 | Pharmacia & Upjohn Company Llc | 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity |
US20040151729A1 (en) * | 2002-10-28 | 2004-08-05 | George Michalopoulos | Novel long-term three-dimensional culture system |
WO2004074245A2 (en) * | 2003-02-14 | 2004-09-02 | Memory Pharmaceuticals Corporation | Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereof |
US7576878B2 (en) * | 2003-04-03 | 2009-08-18 | Hewlett-Packard Development Company, L.P. | Enhanced management of raster image processing resources |
WO2005030145A2 (en) * | 2003-09-24 | 2005-04-07 | Targacept, Inc. | Composition and pharmacology of novel alpha-6-containing nicotinic acetylcholine receptors |
US20070249011A1 (en) * | 2004-03-04 | 2007-10-25 | Riken | Method for Screening Fungus-Specific Antimicrobial Agent and Kit Therefor |
EP1684324B1 (en) * | 2005-01-20 | 2011-01-19 | LG Electronics Inc. | Plasma display panel |
US20060269995A1 (en) * | 2005-02-23 | 2006-11-30 | Nailah Orr | Novel assays utilizing nicotinic acetylcholine receptor subunits |
US7879913B2 (en) * | 2005-06-28 | 2011-02-01 | Catholic Healthcare West | Iptakalim hydrochloride for decreasing nicotine use |
US20190275171A1 (en) * | 2016-09-23 | 2019-09-12 | Ionis Pharmaceuticals, Inc. | Gene therapy and targeted delivery of conjugated compounds |
CN111741760A (en) * | 2017-11-27 | 2020-10-02 | 科达生物治疗医药有限公司 | Compositions and methods for neurological disorders |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4703008A (en) * | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
US4855231A (en) * | 1984-10-30 | 1989-08-08 | Phillips Petroleum Company | Regulatory region for heterologous gene expression in yeast |
US4837148A (en) * | 1984-10-30 | 1989-06-06 | Phillips Petroleum Company | Autonomous replication sequences for yeast strains of the genus pichia |
US4882279A (en) * | 1985-10-25 | 1989-11-21 | Phillips Petroleum Company | Site selective genomic modification of yeast of the genus pichia |
US4859609A (en) * | 1986-04-30 | 1989-08-22 | Genentech, Inc. | Novel receptors for efficient determination of ligands and their antagonists or agonists |
US5071773A (en) * | 1986-10-24 | 1991-12-10 | The Salk Institute For Biological Studies | Hormone receptor-related bioassays |
US5024939A (en) * | 1987-07-09 | 1991-06-18 | Genentech, Inc. | Transient expression system for producing recombinant protein |
US4929555A (en) * | 1987-10-19 | 1990-05-29 | Phillips Petroleum Company | Pichia transformation |
US4981784A (en) * | 1987-12-02 | 1991-01-01 | The Salk Institute For Biological Studies | Retinoic acid receptor method |
CA1341554C (en) | 1988-03-18 | 2007-10-09 | The Salk Institute For Biological Studies | Neuronal nicotinic acetylcholine receptor compositions and assay |
US5449606A (en) * | 1988-03-18 | 1995-09-12 | The Salk Institute For Biological Studies | DNA encoding neuronal nicotinic acetylcholine receptor compositions containing the beta 4 subunit |
US5386025A (en) * | 1990-02-20 | 1995-01-31 | The Salk Institute Biotechnology/Industrial Associates | Calcium channel compositions and methods |
AU3548089A (en) * | 1988-04-04 | 1989-11-03 | Salk Institute Biotechnology/Industrial Associates, Inc., The | Calcium channel compositions and methods |
JP3102877B2 (en) * | 1989-03-14 | 2000-10-23 | ザ・ソーク・インスティチュート・フォー・バイオロジカル・スタディーズ | Neuronal acetylcholine nicotinic acid receptor composition comprising beta 4 subunit |
CA2067216A1 (en) * | 1989-10-25 | 1991-04-26 | Cary Alan Weinberger | Receptor infection assay |
US5091518A (en) * | 1989-11-16 | 1992-02-25 | The Salk Institute For Biological Studies | Beta retinoic acid response elements compositions and assays |
US5369028A (en) * | 1990-04-03 | 1994-11-29 | The Salk Institute Biotechnology/Industrial Associates, Inc. | DNA and mRNA encoding human neuronal nicotinic acetylcholine receptor compositions and cells transformed with same |
US5401629A (en) * | 1990-08-07 | 1995-03-28 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Assay methods and compositions useful for measuring the transduction of an intracellular signal |
WO1994020617A2 (en) | 1993-03-08 | 1994-09-15 | The Salk Institute Biotechnology/Industrial Associates, Incorporated | Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
WO1995013299A1 (en) | 1993-11-08 | 1995-05-18 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
-
1994
- 1994-03-08 WO PCT/US1994/002447 patent/WO1994020617A2/en active IP Right Grant
- 1994-03-08 DE DE69434067T patent/DE69434067T2/en not_active Expired - Fee Related
- 1994-03-08 EP EP94912758A patent/EP0688361B1/en not_active Expired - Lifetime
- 1994-03-08 CA CA002155330A patent/CA2155330C/en not_active Expired - Fee Related
- 1994-03-08 EP EP04077712A patent/EP1508614A1/en not_active Withdrawn
- 1994-03-08 AU AU65173/94A patent/AU694424B2/en not_active Ceased
- 1994-03-08 AT AT94912758T patent/ATE279516T1/en not_active IP Right Cessation
- 1994-03-08 ES ES94912758T patent/ES2229216T3/en not_active Expired - Lifetime
- 1994-03-08 JP JP52024094A patent/JP3628691B2/en not_active Expired - Fee Related
- 1994-03-08 GB GB9503688A patent/GB2286397B/en not_active Expired - Fee Related
-
1995
- 1995-06-05 US US08/467,574 patent/US6022704A/en not_active Expired - Fee Related
- 1995-06-05 US US08/466,589 patent/US5837489A/en not_active Expired - Fee Related
-
1996
- 1996-07-16 US US08/700,636 patent/US5910582A/en not_active Expired - Fee Related
-
1998
- 1998-12-21 US US09/217,345 patent/US6303753B1/en not_active Expired - Fee Related
-
2001
- 2001-06-27 US US09/892,985 patent/US6664375B2/en not_active Expired - Fee Related
-
2004
- 2004-02-05 JP JP2004029558A patent/JP2004194667A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0688361A1 (en) | 1995-12-27 |
WO1994020617A3 (en) | 1994-10-27 |
JP2004194667A (en) | 2004-07-15 |
US5910582A (en) | 1999-06-08 |
DE69434067T2 (en) | 2006-03-02 |
JPH08507441A (en) | 1996-08-13 |
GB9503688D0 (en) | 1995-04-12 |
CA2155330C (en) | 2002-01-29 |
EP1508614A1 (en) | 2005-02-23 |
AU6517394A (en) | 1994-09-26 |
WO1994020617A2 (en) | 1994-09-15 |
US6022704A (en) | 2000-02-08 |
EP0688361B1 (en) | 2004-10-13 |
US6303753B1 (en) | 2001-10-16 |
DE69434067D1 (en) | 2004-11-18 |
GB2286397C (en) | 1997-09-10 |
GB2286397A (en) | 1995-08-16 |
US5837489A (en) | 1998-11-17 |
AU694424B2 (en) | 1998-07-23 |
ES2229216T3 (en) | 2005-04-16 |
GB2286397B (en) | 1997-09-10 |
US6664375B2 (en) | 2003-12-16 |
US20020111463A1 (en) | 2002-08-15 |
JP3628691B2 (en) | 2005-03-16 |
ATE279516T1 (en) | 2004-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2155330A1 (en) | Human neuronal nicotinic acetylcholine receptor compositions and methods employing same | |
AU693747B2 (en) | Imidazo(4,5-c)pyridin-4-amines | |
CA2171618A1 (en) | Purine nucleoside phosphorylase gene therapy for human malignancy | |
EP1770161A3 (en) | BMP-11 compositions | |
SI0866876T1 (en) | Process for the preparation of recombinant proteins in e.coli by high cell density fermentation | |
WO1989009787A3 (en) | Osteogenic devices | |
ZA967562B (en) | Materials and methods relating to the attachment and display of substances on cell surfaces. | |
AU6266496A (en) | Human neuronal nicotinic acetylcholine receptor compositions and methods employing same | |
CA2497857A1 (en) | Novel p-selectin ligand protein | |
CA2306449A1 (en) | Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins | |
GB2287941A (en) | Human neuronal nicotinic acetylcholine receptor compositions and methods employing same | |
AU8209187A (en) | Hybrid proteins | |
CA2085469A1 (en) | Water-soluble polypeptides with strong affinity for .alpha. and .beta. interferons | |
CA2175476A1 (en) | Opioid receptor: compositions and methods | |
HK1006725A1 (en) | T-cell receptor gene located within alpha locus and dna constructions | |
AU8045294A (en) | Methods for producing protein C | |
AU2596888A (en) | Peptide structures, immunogens containing them and their uses in the control of fertility | |
CA2108358A1 (en) | Gene expression in bacilli | |
EP0284205A3 (en) | Carbomycin biosynthetic gene, designated carg, for use in streptomyces and other organisms | |
CA2115151A1 (en) | Tau/neurofilament protein kinases pk40 and pk36 | |
PL313257A1 (en) | Novel tripeptides useful in treating immune system and central nervous system | |
AU1492692A (en) | Co-expression in eukaryotic cells | |
MX9700255A (en) | METHOD FOR IDENTIFYING NUCLEIC ACIDS ENCODING c-fos PROMOTER ACTIVATING PROTEINS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |